Clivarine MDV 1432IU Injection
By Clivarine
Rx
6ml Injection in a Vial

Composition
Reviparin(1432IU)

Manufacturer - Abbott
16th Floor, Godrej BKC, Plot – C, "G" Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Expires on or after
October, 2025

liver
Limited information is accessible concerning the utilization of Clivarine MDV 1432IU Injection in individuals with liver disease. It is crucial to seek guidance from your healthcare provider regarding the use of this medication in such cases.

kidney
Clivarine MDV 1432IU Injection should be used with caution in patients with kidney disease. Dose adjustment of Clivarine MDV 1432IU Injection may be required. Consult your doctor. Avoid use in severe kidney disease.

alcohol
It is unknown whether it is safe to drink alcohol while using Clivarine MDV 1432IU Injection. Please consult your doctor.

driving
It is not known if Clivarine MDV 1432IU Injection affects driving ability. Avoid driving if you have symptoms that impair concentration or reaction time.

pregnancy
Clivarine MDV 1432IU Injection might not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing it. Please consult your doctor for advice.

breastfeeding
Clivarine MDV 1432IU Injection is considered safe during breastfeeding. It is released in small amounts in breast milk, posing minimal risk to the baby. Data indicates no significant harm expected for the baby.
Habit Forming | No |
Chemical Class | Low molecular weight heparin (LMWH) |
Therapeutic Class | BLOOD RELATED |
Action Class | Low molecular weight Heparin (LMWH) |
₹3230
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025